Synlogic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Synlogic and other ETFs, options, and stocks.

About SYBX

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. 

CEO
Mary Beth Dooley
CEOMary Beth Dooley
Employees
1
Employees1
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
1
Employees1

SYBX Key Statistics

Market cap
13.22M
Market cap13.22M
Price-Earnings ratio
-4.34
Price-Earnings ratio-4.34
Dividend yield
Dividend yield
Average volume
100.54K
Average volume100.54K
High today
$1.33
High today$1.33
Low today
$1.10
Low today$1.10
Open price
$1.33
Open price$1.33
Volume
731.73K
Volume731.73K
52 Week high
$1.96
52 Week high$1.96
52 Week low
$0.898
52 Week low$0.898

Stock Snapshot

The current Synlogic(SYBX) stock price is $1.12, with a market capitalization of 13.22M. The stock trades at a price-to-earnings (P/E) ratio of -4.34.

During the trading session on 2025-12-04, Synlogic(SYBX) shares reached a daily high of $1.33 and a low of $1.10. At a current price of $1.12, the stock is +1.8% higher than the low and still -15.8% under the high.

Trading volume for Synlogic(SYBX) stock has reached 731.73K, versus its average volume of 100.54K.

The stock's 52-week range extends from a low of $0.90 to a high of $1.96.

The stock's 52-week range extends from a low of $0.90 to a high of $1.96.

People also own

Based on the portfolios of people who own SYBX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.